Kura Oncology, Inc.
KURA
$7.34
$0.050.69%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 53.88M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.88M | -- | -- | -- | -- |
| Cost of Revenue | 155.35M | -- | -- | -- | -- |
| Gross Profit | -101.46M | -- | -- | -- | -- |
| SG&A Expenses | 24.07M | 18.18M | 16.68M | 18.18M | 14.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.34M | 59.88M | 56.40M | 54.45M | 46.76M |
| Operating Income | -22.46M | -59.88M | -56.40M | -54.45M | -46.76M |
| Income Before Tax | -17.20M | -54.40M | -50.84M | -49.53M | -42.79M |
| Income Tax Expenses | 2.02M | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.22M | -54.40M | -50.84M | -49.53M | -42.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.22M | -54.40M | -50.84M | -49.53M | -42.79M |
| EBIT | -22.46M | -59.88M | -56.40M | -54.45M | -46.76M |
| EBITDA | -22.25M | -59.68M | -56.20M | -54.22M | -46.55M |
| EPS Basic | -0.22 | -0.63 | -0.59 | -0.59 | -0.55 |
| Normalized Basic EPS | -0.22 | -0.39 | -0.37 | -0.37 | -0.42 |
| EPS Diluted | -0.22 | -0.63 | -0.59 | -0.59 | -0.55 |
| Normalized Diluted EPS | -0.22 | -0.39 | -0.37 | -0.37 | -0.42 |
| Average Basic Shares Outstanding | 87.14M | 86.95M | 86.64M | 83.91M | 77.34M |
| Average Diluted Shares Outstanding | 87.14M | 86.95M | 86.64M | 83.91M | 77.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
